Cytisine and derivatives partially prevents the striatal dopamine decrease in an experimental model of Parkinson's disease

J A Abin-Carriquiry, P Iturriaga-Vasquez, G Costa, J Urbanavicius, M Ferreira, B Cassels, S Wonnacott, F Dajas

Research output: Contribution to journalArticlepeer-review

Abstract

There is a negative correlation between smoking and the appearance ofParkinson’s disease. Several experimental evidences support the pro-tective role of nicotinic acetylcholine receptors (nAchR) against avariety of insults in cells in culture and in vivo. Utilizing the intrani-gral 6-OHDA injection model of experimental parkinsonism we havedemonstrated the protective effects of intermittent, subcutaneous nico-tine administration against striatal dopamine decrease. To study the protective capacity of other nAChRs agonists on the dopaminergic ter-minals, the same experimental paradigm was applied in the case of cyti-sine and novel brominated derivatives. An intermittent administrationof 2 mg/kg of cytisine and 1 mg/kg of 5-Br-cytisine, 4 h before and 20,44 and 68 h after 6-OHDA, significantly prevented the striataldopamine decline induced by the nigral lesion. The effect was not wellcorrelated with the a4b2 or a7 ligand binding potency and with the potency and efficacy to induce dopamine release in the corpus striatum.
Original languageEnglish
Article numberP.67
Pages (from-to)47
Number of pages1
JournalJournal of Neurochemistry
Volume94
Issue numberSupplement 1
DOIs
Publication statusPublished - Aug 2005
Event20th Biennial Meeting of the International Society for Neurochemistry and the European Society for Neurochemistry - Innsbruck, Austria
Duration: 21 Aug 200526 Aug 2005

Fingerprint Dive into the research topics of 'Cytisine and derivatives partially prevents the striatal dopamine decrease in an experimental model of Parkinson's disease'. Together they form a unique fingerprint.

Cite this